Rankings
▼
Calendar
RAPP FY 2022 Earnings — Rapport Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
RAPP
Rapport Therapeutics, Inc. Common Stock
$1B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$15,000
Operating Income
-$10M
Net Income
-$11M
EPS (Diluted)
$-0.05
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$609,818
Balance Sheet
Total Assets
$32M
Total Liabilities
$12M
Stockholders' Equity
$20M
Cash & Equivalents
$31M
← Q1 2023
All Quarters
